Reversible Mitochondrial Respiratory Chain Impairment during Symptomatic Hyperlactatemia Associated with Antiretroviral Therapy

AIDS Research and Human Retroviruses

Volumn 19, Issue 11, 2003, Pages 1027-1032

  Miró, Òscar ^a,c   López, Sònia ^a   Martínez, Esteban ^a   Rodríguez Santiago, Benjamín ^b   Blanco, José L ^a   Milinkovic, Ana ^a   Miró, Jose M ^a   Nunes, Virginia ^b   Casademont, Jordi ^a   Gatell, Josep M ^a   Cardellach, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; MITOCHONDRIAL DNA; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; CASE REPORT; CELL DAMAGE; DISEASE ASSOCIATION; DNA CONTENT; ENZYME ACTIVITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERLACTATEMIA; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SKELETAL MUSCLE; SYMPTOM; ARTICLE; BIOPSY; ELECTRON TRANSPORT; ENZYMOLOGY; GENETICS; LACTIC ACIDOSIS; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ACIDOSIS, LACTIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL;

EID: 0344394256     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322588387     Document Type: Review

References (20)

1. John M, Moore CB, James IR, et al.: Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 2001; 15:717-723.
2. Falcó V, Rodríguez D, Ribera E, et al.: Severe nucleoside-associated lactic acidosis in HIV-infected patients. Report of 12 cases and analytical review of the literature. Clin Infect Dis 2002;34: 838-846.
3. Grau JM, Masanes F, Pedrol E, et al.: Human immunodeficiency virus type 1 infection and myopathy: Clinical relevance of zidovudine therapy. Ann Neurol 1993;34:206-211.
4. Gómez M, Miró O, Pedrol E, et al.: Mitochondrial involvement in antiretroviral therapy-related lipodystrophy. AIDS 2001;15: 1643-1651.
5. Chariot P, Drogou I, Lacroix-Szmania I, et al.: Zidovudine-induced mitochondrial disorder with massive lever steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 1999;30: 156-160.
6. Gérard Y, Maulin L, Yazdanpanah Y, et al.: Symptomatic hyperlactataemia: An emerging complication of antiretroviral therapy. AIDS 2000;14:2723-2730.
7. Carr A, Morey A, Mallon P, et al.: Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia. Lancet 2001;357: 1412-1414.
8. Church JA, Mitchell WG, Gonzalez-Gomez I, et al.: Mitochondrial DNA depletion, near-fatal metabolic acidosis, and liver failure in an HIV-infected child treated with combination antiretroviral therapy. J Pediatr 2001;138:748-751.
9. Côté H, Brumme ZL, Craib KJP, Alexander CS, Wynhoven B, Ting L, et al.: Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002;346:811-820.
10. Casademont J, Miró O, and Cardellach F: Mitochondrial DNA and nucleoside toxicity. N Engl J Med 2002;347(3):216-218.
11. Miró O, Pedrol E, Casademont J, et al.: Muscle involvement in rheumatoid arthritis: Clinicopathological study of 21 symptomatic cases. Semin Arthritis Rheum 1996;25:421-428.
12. Miró O, Casademont J, Casals E, et al.: Aging is associated with increased lipid peroxidation in human hearts, but not with mitochondrial respiratory chain enzyme defects. Cardiovasc Res 2000;47:624-631.
13. Rustin P, Chretien D, Bourgeron T, et al.: Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51.
14. Miró O, Barrientos A, Alonso JR, et al.: Effects of general anaesthetic procedures on mitochondrial function of human skeletal muscle. Eur J Clin Pharmacol 1999;55:35-41.
15. Rodriguez-Santiago B, Casademont J, and Nunes V: Is mitochondrial DNA depletion involved in Alzheimer's disease? Eur J Hum Genet 2001;9(4):279-285.
16. Morrison TB, Weis JJ, and Witter CT: Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998;24:954-958, 960-962.
17. Ririe KM, Rasmussen RP, and Wittwer CT: Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 1997;245:154-160.
18. Chance DS and McIntosh MK: Hypolipidemic agents alter hepatic mitochondrial respiration in vitro. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1995;111:317-323.
19. Roge BT, Calbet JA, Moller K, Ullum H, Hendel HW, Gerstoft J, and Pedersen BK: Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels. AIDS 2002;16: 973-982.
20. Miró O, Gómez M, Pedrol E, Cardellach F, Nunes V, and Casademont J: Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy. AIDS 2000;14:1855-1857.